Newsroom

Welcome to Blood Cancer United Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Research February 9, 2023

Faron Announces Results of Placing, Including Additional Investment by The Leukemia & Lymphoma Society Therapy Acceleration Program®

TURKU, FINLAND / BOSTON, MA - January 27 2023 - Faron Pharmaceuticals Ltd (First North: FARON, AIM: FARN), a clinical stage biopharmaceutical company …

Patient Education Webcasts February 2, 2023

CAR T-Cell Therapy and Blood Cancers

News February 1, 2023

Sharing Decades of a Dedicated Vision to End Cancer

January 30, 2023

LLS Community Corner Log In Instructions

News January 27, 2023

FDA Approves New Type of BTK Inhibitor to Treat Mantle Cell Lymphoma

The U.S. Food and Drug Administration today approved pirtobrutinib (Jaypirca™), the first non-covalent, reversable BTK inhibitor for the treatment of …

January 17, 2023

Apoyo Económico

January 17, 2023

Alivio financiero

Research January 17, 2023

Encouraging Additional Data for Bexmarilimab for the Treatment of Hematological Malignancies

January 16, 2023 - TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company …

Research January 17, 2023

BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 Million Strategic Equity Investment

Lund, Sweden – January 17, 2023 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and de…

January 10, 2023